Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Inflamm Bowel Dis. 2013 Mar;19(3):627–643. doi: 10.1002/ibd.22986

Table 5.

Clinical outcomes.

Study Subjects Setting Outcomes studied Race- or SES-based differences identified? Relevant data
Nguyen, 200623 N=23,389
AA=2,288
H=1,834
W=18,368
Other=899
UC inpatients included in NIS from 1998-2003 • In-hospital mortality Yes (SES)
No (race)
• Odds of in-hospital mortality 3.3 times greater for Medicaid patients than privately insured patients
• Crude in-hospital mortality was 0.91 per 1,000 hospital days among AA compared with 1.30 per 1,000 for W (P=NS)
Nguyen, 200719 N=41,918
A=269
AA=4,760
W=34,388
Other=816
CD inpatients included in NIS from 1998-2003 • In-hospital mortality Yes (SES)
No (race)
• Income below the median associated with 29% increased risk of in-hospital mortality
• Crude in-hospital mortality was 6.6 per 10,000 hospital days for W, 6.4 per 10,000 for AA, 9.7 per 10,000 for H (P=NS)
• A had statistically lower in-hospital mortality (0 deaths) compared with other races
Hoie, 200736 N=771 UC outpatients from multiple centers in Europe and Israel • Disease relapse Yes (SES) • Overall 10-year relapse risk 67%
• Higher education associated with 40% increased odds of first relapse
• Educational status not associated with risk of subsequent relapse
Sentongo, 200237 N=112
AA=9
W=101
Other=2
CD inpatients at single university hospital • Vitamin D status Yes (race) • 56% of AA had hypovitaminosis D, compared with only 13% of W

A, Asians; AA, African Americans; CD, Crohn's disease; NIS, Nationwide Inpatient Sample; SES, socioeconomic status; UC, ulcerative colitis; W, whites